Hubei Mon Yan Pharmaceutical Co., Ltd Report issue

Government

Organization Overview

First Clinical Trial
2018
NCT03413358
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Hubei Mon Yan Pharmaceutical Co., Ltd

Active Ingredients

Drugs in Other Trials (3)

carboplatin (paraplatin) (1 trial)

cisplatin (platinol) (1 trial)

sheng bai (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 3